ArticleMagnetic resonance in medicine2026
Multi-Contrast Human Brain CEST MRI at 11.7 T: First In Vivo Demonstration.
Article in Magnetic resonance in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
purposeTo implement and evaluate chemical exchange saturation transfer (CEST) at ultra-high field on a whole-body 11.7 T scanner using parallel transmission (pTx).
methodsTailored pTx CEST saturation pulses were optimized to achieve a spatially uniform target B
resultsThe pTx pulse designs optimized under VOP-based SAR constraints at 11.7 T achieved comparable performance to 7 T designs despite higher intrinsic B
conclusionVOP-based SAR-constrained pTx CEST saturation pulse design enabled robust and reproducible contrast at 11.7 T by effectively mitigating B
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.